Achaogen

AKAO

12.20

-0.20

-1.6%

After Hours:

12.20

0.00

0.0%

Please Login or Register

Login|Register FREE

Stock Price
Open: 12.44
Prev. Close: 12.40
Low/Hi: 12.11 - 12.61
52-Week: 4.73 - 27.79
Volumes
Equity: 499,940
90-Day Avg: 736,028
Option: 200
90-Day Avg: 439
Volatility
Todays Stock Vol: 34.5
20-Day (HV): 88.1
52-Week (HV): 70.1
30-Day IV: 73.7 +1.2
IV Pct Rank: 62% Moderate
Fundamental
Div. Yield:
Earnings: 15-Mar (Est.)
P/E Ratio:
Market Cap: 525.7 M
Stock Info
Type: Common
Sector: Healthcare
Industry: Biotechnology

AKAO Cash Flow

Numbers are in thousands. Data provided by Sage Data Service.
Period Ending 30-Sep-2017 30-Jun-2017 31-Mar-2017 31-Dec-2016
Net Income -29,907 -26,070 -33,259 -29,724
Change in Working Capital 2,799 6,247 1,696 -676
Depreciation Amortization Depletion and Accretion 348 288 71 134
Deferred Taxes 0 0 0 0
Other Non-Cash Activities -2,680 -446 18,074 18,359
Total Cash from Operating Activities -29,440 -19,980 -13,418 -11,907
Capital Expenditures -2,056 -2,036 -1,185 -467
Other Investing Cash Flow 21,663 8,150 -67,503 -7,400
Total Cash from Investing Activities 19,607 6,114 -68,688 -7,867
Dividends and Distributions 0 0 0 0
Purchase or Sale of Stock 202 122,415 781 97,186
Purchase and Retirement of Debt -1,042 0 0 0
Other Financing Cash Flow 0 0 0 0
Total Cash from Financing Activities -840 122,415 781 97,186
Exchange Rate Effects 0 0 0 0
Net Change in Cash -10,673 108,549 -81,325 77,412
Period Ending 31-Dec-2016 31-Dec-2015 31-Dec-2014
Net Income -71,227 -27,093 -20,176
Change in Working Capital -868 1,775 2,977
Depreciation Amortization Depletion and Accretion 745 926 615
Deferred Taxes 0 0 0
Other Non-Cash Activities 24,447 3,304 2,301
Total Cash from Operating Activities -46,903 -21,088 -14,283
Capital Expenditures -901 -606 -340
Other Investing Cash Flow 11,269 5,838 -45,087
Total Cash from Investing Activities 10,368 5,232 -45,427
Dividends and Distributions 0 0 0
Purchase or Sale of Stock 125,462 2,672 74,749
Purchase and Retirement of Debt 10,000 14,590 -6,896
Other Financing Cash Flow 0 0 0
Total Cash from Financing Activities 135,462 17,262 67,853
Exchange Rate Effects 0 0 0
Net Change in Cash 98,927 1,406 8,143